Negative Life Events in Childhood Tied to Depressive Symptoms in Young Adulthood
Medically reviewed by Drugs.com.
By Lori Solomon HealthDay Reporter
TUESDAY, Dec. 12, 2023 -- Negative life events (NLE) in childhood and early adolescence predict depressive symptoms in young adulthood and may be identifiable before symptoms through structural magnetic resonance imaging (MRI), according to a study published online Dec. 6 in JCPP Advances.
Lea L. Backhausen, from the Dresden University of Technology in Germany, and colleagues examined whether NLE during childhood and early adolescence predict depressive symptoms in young adulthood through accelerated orbitofrontal cortex (OFC) thinning across adolescence. The analysis included longitudinal data from 321 participants with structural MRI at two sites across four time points from ages 14 to 22 years.
The researchers found that young adult depressive symptoms were predicted by a higher burden of NLE, a thicker OFC at the age of 14 years, and an accelerated OFC thinning across adolescence. There was no effect of NLE on OFC thickness nor OFC thickness mediating effects of NLE on depressive symptoms.
"Using a complete longitudinal design with four waves, we show that NLE in childhood and early adolescence predict depressive symptoms in the long term. Results indicate that an accelerated OFC thinning may precede depressive symptoms," the authors write. "Assessment of early additionally to acute NLEs and neurodevelopment may be warranted in clinical settings to identify risk factors for depression."
Two authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2023-12-13 22:15
Read more
- Lack of Insurance Could Mean Later Cancer Diagnoses for Black, Hispanic Americans
- Palleon Pharmaceuticals Presents Results from the Phase 1/2 GLIMMER-01 Trial of E-602 in Combination with Cemiplimab in Patients with Solid Tumors at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
- Darling Ingredients Announces Publication of Peer-Reviewed Collagen Peptides Study and its Impact on Post-Meal Blood Glucose Spikes
- Glaukos Announces Positive Topline Outcomes in Phase 3 Confirmatory Trial for Epioxa, Achieving Primary Efficacy Endpoint and Demonstrating Favorable Tolerability and Safety
- Poor Cardiovascular Health Linked to Composite of Poor Brain Health
- Ketamine ODs Like the One That Killed Matthew Perry Are Rare But Increasing
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions